Okoli George N, Racovitan Florentin, Abdulwahid Tiba, Hyder Syed K, Lansbury Louise, Righolt Christiaan H, Mahmud Salaheddin M, Nguyen-Van-Tam Jonathan S
College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Vaccine and Drug Evaluation Centre, University of Manitoba, Winnipeg, Manitoba, Canada.
Open Forum Infect Dis. 2021 Feb 5;8(3):ofab069. doi: 10.1093/ofid/ofab069. eCollection 2021 Mar.
Evidence suggests that repeated influenza vaccination may reduce vaccine effectiveness (VE). Using influenza vaccination program maturation (PM; number of years since program inception) as a proxy for population-level repeated vaccination, we assessed the impact on pooled adjusted end-season VE estimates from outpatient test-negative design studies.
We systematically searched and selected full-text publications from January 2011 to February 2020 (PROSPERO: CRD42017064595). We obtained influenza vaccination program inception year for each country and calculated PM as the difference between the year of deployment and year of program inception. We categorized PM into halves (cut at the median), tertiles, and quartiles and calculated pooled VE using an inverse-variance random-effects model. The primary outcome was pooled VE against all influenza.
We included 72 articles from 11 931 citations. Across the 3 categorizations of PM, a lower pooled VE against all influenza for all patients was observed with PM. Substantially higher reductions were observed in older adults (≥65 years). We observed similar results for A(H1N1)pdm09, A(H3N2), and influenza B.
The evidence suggests that influenza VE declines with vaccination PM. This study forms the basis for further discussions and examinations of the potential impact of vaccination PM on seasonal VE.
有证据表明,重复接种流感疫苗可能会降低疫苗效力(VE)。我们以流感疫苗接种计划成熟度(PM;自计划启动以来的年数)作为人群水平重复接种的替代指标,评估其对门诊检测阴性设计研究中汇总调整后的季末疫苗效力估计值的影响。
我们系统检索并筛选了2011年1月至2020年2月期间的全文出版物(国际前瞻性系统评价注册库:CRD42017064595)。我们获取了每个国家的流感疫苗接种计划启动年份,并计算PM为实施年份与计划启动年份之差。我们将PM分为两半(按中位数划分)、三分位数和四分位数,并使用逆方差随机效应模型计算汇总疫苗效力。主要结局是针对所有流感的汇总疫苗效力。
我们从11931条引用中纳入了72篇文章。在PM的三种分类中,所有患者针对所有流感的汇总疫苗效力均随PM降低。在老年人(≥65岁)中观察到的降幅明显更大。对于甲型(H1N1)pdm09、甲型(H3N2)和乙型流感,我们观察到了类似的结果。
有证据表明,流感疫苗效力随疫苗接种计划成熟度下降。本研究为进一步讨论和研究疫苗接种计划成熟度对季节性疫苗效力的潜在影响奠定了基础。